The winners of the 2026 Falk Foundation /BASL /Liver UK Awards were announced last week at a ceremony held during the BASL Annual Meeting at the ICC in Wales. Many congratulations to team leaders Dr Ahmed Ibrahim, South Tees Hospitals NHS Foundation, Dr Naveenta Kumar and Ms Abigail Greewell, Royal Free Londonand Dr Thendral Managala, Royal Free London on this hugely deserved and meaningful success.
Now in their fourth year, these awards were founded to celebrate innovation, quality and service improvement in liver disease and to recognise the value of teamwork in achieving these goals. In doing so, the awards reflect the Falk Foundation ethos of encouraging innovations in hepatology and improvement in patient care along with supporting clinical collaboration in this field. All the team leaders were quick to acknowledge the vital contribution of their respective colleagues, who provided crucial ongoing support for the winning projects, often in their own time. Winning projects this year included the development of Cirrhosis Rehabilitation Programme which harnessed the combined skills of an MDT to focus on improving frailty and quality of life in patients, the launch of hepatitis B weekend clinics aiming to improve patient attendance and engagement, and a process to improve HCC Surveillance through the introduction of a novel automated cirrhosis recall system.
The winners received their prize and certificate from BASL President, Dr Ian Rowe, along with Ms Pamela Healy OBE CEO of Liver UK, and Mrs Maya Vlahovic, the Falk Foundation Manager UK & Ireland. Following the presentation ceremony on Thursday 9th October, which was attended by colleagues from across the hepatology community, the winners were hosted at a celebratory dinner.
Dr Ian Rowe notes: “This is the fourth year of our extremely successful collaboration with the Falk Foundation UK & Dr Falk Pharma Uk together with Liver UK (formerly British Liver Trust), enabling us, once again, to reward the incredible work carried out by our members to improve the care of people living with liver disease through their innovation and service improvements. The hard work and dedication shown by our worthy winners – often working on these projects in their own time – is humbling and we are looking forward congratulating all the winners at the BASL Annual Meeting at the ICC in Wales.”
Chief Executive at Liver UK, Pamela Healy comments: Dr Kumar and Ms Greenwell, who received the Quality and Service Improvement Award for their project ‘A Novel Multidisciplinary Cirrhosis Rehabilitation Programme to Improve Frailty and Quality of Life in Patients’ commented on winning the award:
“This award is a wonderful recognition of the hard work, dedication and passion of everyone involved. This has been an incredibly fulfilling project to work on. We know of two patients who attended the clinics who subsequently became fit enough to have a liver transplant, which was life saving for them. We feel extremely grateful to be part of such a committed team, and proud that our work is helping to make a real difference to the lives of people living with cirrhosis.”
Dr Darren Craig mentored the team from South Tees Hospital. He explains: “Ahmed and our hepatology team have delivered an important improvement in our HCC surveillance reflecting outstanding multidisciplinary working. Dr Ibrahim has shown considerable clinical leadership, determination and attention to patient safety throughout, bringing different teams together to deliver this improvement for our patients.”
Dr Mangala, winner of the Innovation Award notes: ‘I am passionate about finding a way to encourage our patients to receive effective long-term monitoring and, at the same time, to destigmatise this condition. Winning this award is a validation that this project is worthwhile and has encouraged me to continue my work in this area.’
Ms Maya Vlahovic concludes: “The Falk Foundation is committed to promoting the exchange of knowledge and innovation within gastroenterology and hepatology and supporting clinicians as they work to improve outcomes for patients. We are proud therefore, to partner once again with BASL and Liver UK to showcase and reward best practice and innovation and service improvement for the patients living with liver disease.”



